Invest in the power of pharmaceutical pipelines

HOW AI IS SUPERCHARGING THE SECTOR

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

CITY

Last year saw record consolidation and corporate action in the investment trust sector. If the past seven months are anything to go by, 2025 will be a year of note, as well. At the beginning of the ye

Issue of the week: the battle for weight-loss ...

UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a